ARTV   $12.1  -5.32% Market Closed After Close 12.17 0.58%

Artiva Biotherapeutics Inc
Total Cash 46.56M
totalCashPerShare 1.917
EBITDA -29.50M
Total Debt 15.77M
quickRatio 4.444
currentRatio 4.595
Total Revenue 29.26M
debtToEquity 62.273
Revenue/Share 36.149
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -50.19M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins -1.0083699
operatingMargins -1.08836
profitMargins -1.11174
enterpriseValue 515.93M
forwardPE -3.9449275
floatShares 4.02M
sharesOutstanding 24.29M
sharesShort 840.87K
sharesShortPriorMonth 51.33K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.21%
heldPercentInstitutions 0.68%
Short Ratio help_outline 3.01%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -234.705
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -32.52M
trailingEps -0.93%
forwardEps -3.45%
enterpriseToEbitda -17.49
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.91 3Q 2024
institutionsCount 9
lastUpdated Oct. 17, 2024, 6:32 p.m.